SHIRENE WOODHAM: Open Payments
NPI 1326527508 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 63 payments from 18 companies in 2025. Trend: 2023 $750 · 2024 $564 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $664 |
| Novo Nordisk Inc | 6 | $195 |
| AstraZeneca Pharmaceuticals LP | 5 | $147 |
| Lilly USA, LLC | 3 | $59 |
| Astellas Pharma US Inc | 2 | $43 |
| Dexcom, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| TOLMAR, INC. | 2 | $30 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
Products named: VRAYLAR, QULIPTA, Ozempic, AIRSUPRA, UBRELVY, MOUNJARO, Wegovy, Veozah.
Industry payments across AZ — which companies pay providers there.
